HBV Forum 6

E-mail Print

HBV Forum 6 was held in Boston, MA on November 7th, 2019.

 

pdf Agenda

pdfParticipants

 

Presentations

pdf Welcoming Remarks
       Jessica Weber, The Forum for Collaborative Research

Session I: Field Updates

pdf What's Hot at The Liver Meeting?
       Edward Gane, University of Auckland

pdf FDA Draft Guidance: Chronic Hepatitis D Virus Infection
       Aimee Hodowanec, U.S. Food & Drug Administration

pdf Hepatitis B Study Update
       Scott Harris, Altimmune, Inc.

Session II: Regulatory Consideration Panel Topics

pdf Panel 3: Core Inhibitor Sub-Classes and Mechanisms of Action
       Oliver Lenz, Janssen

Session III: HBV Forum Updates

pdf Immune Monitoring Working Group
       Adam Gehring, Toronto Centre for Liver Disease

pdf Liver Safety Monitoring Manuscript (JVH)
       Robert Fontana, University of Michigan

pdf HBsAg Loss Meta-Analysis
       Hannah Choi, Toronto Centre for Liver Disease

pdf Planned Collaboration: Stop Nuc Studies
       Jordan Feld, University Health Network

Session V: Field Updates and Special Debate

pdf ICE-HBV: Global Fund & Messaging Briefing
       Massimo Levrero, ICE-HBV Board

pdf Special Debate: The Case for Test and Treat All HBV Patients
       Homie Razavi, Center for Disease Analysis Foundation

pdf Special Debate: Just Say No to Test and Treat for HBV
       Brian McMahon, Alaska Native Tribal Health Consortium